TO: Iowa Public Department of Health

FROM: Heather Adams, Assistant Attorney General

Date: October 28, 2009

RE:  Public Readiness and Emergency Preparedness (PREP) Act for H1N1 Vaccination and Emergency Use Authorizations (EUAs) for H1N1 Countermeasures

 
Top News arrow Whistleblowers
Whistleblowers Break the Silence
Under Fire, FDA's Top Cop Steps Down Print E-mail
Tuesday, 30 November 2010

"The thought that someone at the GAO may have compromised the testing of a system unfortunately, brings the integrity of the entire report into question if it’s determined to be true." Sen. Charles Grassley.

Read more...
 
Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs Print E-mail
Sunday, 03 October 2010
"When you’re selling $1 billion a year or more of a drug, it’s very tempting for a company to just ignore the traffic ticket and keep speeding.”
Read more...
 
Former Sen Finance Committee Investigator Speaks Out Print E-mail
Thursday, 23 September 2010
"What’s gone on with the pharmaceutical industry is a physician arms race to buy off doctors..."
Read more...
 
Globalization of Pediatric Drug Trials--For Whose Benefit? Print E-mail
Thursday, 26 August 2010

There is no evidence to indicate that children have been the beneficiaries of the Pediatric Exclusivity Provision of FDAMA (enacted in 1998): there is evidence that pharmaceutical companies have increased their profits from the legislation by at least $14 billion.  

Read more...
 
Making a Killing--Marketing Exercises by Dr. Carl Elliott Print E-mail
Monday, 23 August 2010
The catalyst for Dr. Elliott's article was the tragic case of Dan Markingson, a 26-year old who committed suicide in May 2004, while enrolled in the CAFE trial, prescribed Seroquel. This case encapsulates the tragic consequences of a broken system which is not designed to detect the hazards for human subjects posed by market-driven research.
Read more...
 
More...
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 10 - 18 of 136
[ Back ]
(C) 2012 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]